COMMUNIQUÉS West-GlobeNewswire

Novartis advances head-to-head superiority trials of Cosentyx® versus Humira®* and proposed biosimilar adalimumab**
09/01/2018
SURPASS is the first head-to-head superiority trial versus proposed biosimilar adalimumab** in ankylosing spondylitis (AS)[1] EXCEED is the first head-to-head superiority trial versus Humira ® * in psoriatic arthritis ( [...]
Cannabis Wheaton Income Corp. Announces Strategic Investment and Alliance With Inner Spirit Holdings Ltd.
09/01/2018
VANCOUVER, British Columbia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: CBW ) (" Wheaton Income " or the " Company ") is pleased to announce that it has entered into [...]
Breathtec Biomedical Unaware of Any Material Change
09/01/2018
VANCOUVER, British Columbia, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Breathtec Biomedical, Inc. (CSE:BTH) (OTCQB:BTHCF) (the “ Company ” or “ Breathtec ”) - at the request of the Investment Industry Regulatory Organization of [...]
Quotient Limited Reports Further Positive Data on its Initial Disease Screening Microarray and Provides Update on Blood Grouping
09/01/2018
Performance evaluation studies for the initial disease screening microarray demonstrate 100% sensitivity and >99% specificity for the CMV and Syphilis assays V&V for blood grouping is ongoing – pending a [...]
Cannabis Wheaton Income Corp. Announces Increase of Previously Announced Private Placement Financing of Convertible Debenture Units to up to $100 Million
09/01/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V: [...]
BioSyent Announces Changes to Its Board of Directors
09/01/2018
TORONTO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”) (TSX Venture:RX) today announced the retirement of two long-serving Directors, Mr. Douglas Larson and Mr. Milton Wakefield, from its Board of [...]
Compass Cannabis Clinics and Starbuds Announce Canadian Joint Venture
08/01/2018
CALGARY, Alberta, Jan. 08, 2018 (GLOBE NEWSWIRE) -- 10330698 Canada Ltd. (dba Compass Cannabis Clinics (" Compass Cannabis " or the " Company ")) is pleased to announce that it has signed a binding letter agreement with [...]
Adamas Announces U.S. Commercial Launch of GOCOVRI™ the First and Only FDA-approved Medication for the Treatment of Dyskinesia in Parkinson’s Disease Patients
08/01/2018
EMERYVILLE, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced the full commercial launch of its flagship product, GOCOVRI™ (amantadine) extended release capsules, for [...]
ConforMIS Reports Preliminary Fourth Quarter and Year-End 2017 Revenue Results; Provides 2018 Financial Guidance
08/01/2018
BILLERICA, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ: CFMS ), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell [...]
Tabula Rasa HealthCare to Participate in the 20th Annual Needham Growth Conference
08/01/2018
MOORESTOWN, N.J., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC ), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation digital [...]
Sarepta Therapeutics Pre-Announces Fourth Quarter 2017 Revenue and Provides Full-Year 2018 Revenue Guidance for EXONDYS 51® (eteplirsen), Representing Approximately 100 Percent Year-over-Year Growth
08/01/2018
-- Fourth quarter 2017 EXONDYS 51 unaudited revenue of $57.3 million -- -- Full-year 2017 EXONDYS 51 unaudited revenue of $154.6 million -- -- Full-year 2018 EXONDYS 51 revenue guidance of $295 – $305 million -- -- 16 [...]
Vaccinex, Inc. Announces Research Collaboration Employing ActivMAb® Platform Technology and Antibody License Option Agreement with Surface Oncology
08/01/2018
ROCHESTER, N.Y., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc., a privately-held clinical-stage biotechnology company engaged in the development of therapeutic monoclonal antibodies to treat patients with cancer and [...]
I-MED Pharma partners with OCuSOFT to bring the I-PEN® Osmolarity System to the U.S.A.
08/01/2018
MONTREAL, Jan. 08, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with OCuSOFT Inc. for [...]
Nuvectra™ Announces Preliminary Unaudited Fourth Quarter and Full Year 2017 Revenue
08/01/2018
PLANO, Texas, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, today announced preliminary unaudited revenue for the fourth quarter and full year ended [...]
Teladoc Completes Record Visit Volume in 2017; Provides Preliminary Unaudited 2017 Results and 2018 Financial Outlook
08/01/2018
PURCHASE, NY, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), today announced certain preliminary unaudited 2017 results and financial outlook for 2018. “For Teladoc, 2017 marked a landmark year as we [...]
Establishment Labs Appoints Dennis Condon to the Board of Directors
08/01/2018
NEW YORK, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Establishment Labs, a global medical device company focused on breast aesthetics and reconstruction technologies with a strong emphasis on product development and innovation, [...]
GUERBET : Guerbet announces its acquisition of Accurate Medical Therapeutics, an innovative company that develops microcatheters for interventional radiology
08/01/2018
Acceleration of the interventional radiology strategy Acquisition of a unique technology for image-guided embolization procedures Villepinte (France), January 8, 2018 (17:45 CET) - Guerbet (FR0000032526 GBT), a global [...]
GUERBET : Guerbet annonce l'acquisition d'Accurate Medical Therapeutics, société innovante dans les microcathéters pour la radiologie interventionnelle
08/01/2018
Accélération de la stratégie en radiologie interventionnelle Acquisition d'une technologie unique pour les procédures d'embolisation guidées par l'image Villepinte (France), le 8 janvier 2018 (17h45 heures CET) - [...]
ABLYNX ANNOUNCES BOARD CHANGES
08/01/2018
8 January 2018 - 5:30 pm CET GHENT, Belgium, 8 January 2018 (5:30 pm CET) - Ablynx NV [Euronext Brussels and Nasdaq: ABLX] today announced that Dr Peter Fellner, who has served as Chairman since 2013 [1] , has decided [...]

Pages